Publications by authors named "Pedram Molhem Azar"
Background: Nail involvement in subepidermal autoimmune blistering diseases (SEABD) is not common. Although these changes can be transient, permanent changes can also occur. This study addresses nail involvement manifestations and their associated factors in patients with SEABD.
View Article and Find Full Text PDFRituximab (RTX) combined with short-term glucocorticoids (GC) is an effective therapeutic option for pemphigus. The newly developed Glucocorticoid Toxicity Index (GTI) tool provides the possibility to measure GC toxicities over time. To compare 1-year GTI between two groups of RTX-treated and RTX-naïve patients with pemphigus.
View Article and Find Full Text PDFLichen planopilaris (LPP) is a scarring alopecia for which no treatment with remarkable effect has been identified. Pioglitazone has been reported as a possible therapeutic option. To compare the efficacy and safety of pioglitazone with clobetasol in LPP.
View Article and Find Full Text PDFBotulinum toxin injection as a single or combined treatment with non-cross-linked high molecular weight and low molecular weight hyaluronic acid gel for neck rejuvenation: A randomized clinical trial.
Dermatol Ther
October 2022
Article Synopsis
- The study investigates the effectiveness of botulinum toxin injections combined with Profhilo gel for neck rejuvenation compared to botulinum toxin alone.
- Patients were divided into two groups, with one receiving only Dysport Botox and the other receiving Dysport followed by Profhilo gel two weeks later.
- Results showed that the group receiving Profhilo gel had significantly improved skin hydration, thickness, and aesthetic outcomes after three months, indicating it as a safer and more effective treatment option for aging neck skin.
The ongoing COVID-19 pandemic has raised concerns regarding the outcome of this infection in patients with autoimmune bullous dermatoses (AIBDs) due to effect of drugs used to treat these disorders. This investigation was performed from the onset of the pandemic to June 1, 2021. Patients with AIBDs who contracted COVID-19 were evaluated.
View Article and Find Full Text PDFObjectives: This study determines the healing time of lesions on different locations and the contributing factors to the healing time in patients with pemphigus.
Methods: In this prospective study, newly diagnosed patients with mucosal lesions were included. A dermatologist evaluated the lesions, disease status, side effects and assigned the PDAI.